News

Ortho Baltic is proud to announce the organisation of a pre-surgical planning webinar using MICE between the 8th to 10th of March. During a 2h session, you will be introduced with the concept behind MICE and its workflow leading from your idea to the surgery and we will explore together the possibilities of MICE 3D […]

The first launch of 3D pre-surgical planning software oversees took place in San Diego, during the annual American conference designed for the clinicians, innovators, investors, executives, and makers driving progress in smart ways

The virtual planning and patient-specific devices are rapidly making their way into becoming a gold standard in surgical treatment of complex clinical cases for patients suffering from severe deformities caused by congenital or acquired conditions, or oncological masses.

A 12-minute video of the research and innovation project INOVER 21, implemented by the Lithuanian company Ortho Baltic, appeared on YouTube. The video presents the advantages of patient-specific implants versus standard off shelf implants and the main results of the INOVER 21 project

All of the virtues that this rapid growth brings to the medical device industry and the patients suffering from complex pathologies, are already re shaping current medical device regulation

Patient-specific implants currently fail to achieve large-scale commercial success over much inferior standard orthopaedic, maxillofacial and neurosurgical implants due to high price, long lead times, surgical approach oriented towards standard solutions.

The switch to personalized medicine is already slowly taking place due to changing trends in healthcare itself and in healthcare compensation systems – the payments from ‘per no. of treatments’ progressively moving to ‘outcomes of treatment’.

The conservative assessment of the Patient-specific implants (further PSI) market only includes the clinical cases where the use of PSI has no alternative among standard implants, which occurs in about 2% cases.